Active Ingredient: DEFERASIROX
Proprietary Name: DEFERASIROX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 180MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A211395
Product Number: 002
Approval Date: Mar 22, 2024
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information